Status:
COMPLETED
Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This trial is conducted in North America. The aim of this trial is to investigate the efficacy of biphasic insulin aspart 30 in subjects with type 2 diabetes not achieving glycaemic targets on OADs (o...
Eligibility Criteria
Inclusion
- Type 2 diabetes mellitus for at least 12 months
- HbA1c between 7.5-14.5% (inclusive) at screening
- Insulin naïve
- An antidiabetic regimen that has been stable for at least 3 months prior to screening
- An antidiabetic regimen that includes a minimum of 2 OADs
Exclusion
- Use of any insulin preparations within the past 6 months
- Active proliferative retinopathy or maculopathy requiring treatment within 6 months prior to screening
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT01486862
Start Date
October 1 2005
End Date
July 1 2006
Last Update
November 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pachuca, Mexico, 42060